Exact Sciences Corp (NAS:EXAS)
$ 53.34 -0.66 (-1.22%) Market Cap: 9.84 Bil Enterprise Value: 11.87 Bil PE Ratio: 0 PB Ratio: 3.13 GF Score: 80/100

Exact Sciences Corp at Cowen Health Care Conference Transcript

Mar 06, 2023 / 03:30PM GMT
Release Date Price: $67.03 (-0.71%)
Daniel Gregory Brennan
Cowen and Company, LLC, Research Division - Senior Tools & Diagnostics Analyst

So great. Thank you. Thanks for being here. Dan Brennan. Day 1 of the TD Cowen Healthcare Conference. Pleased to be joined with me on stage here, senior management team of Exact Sciences. We have Kevin Conroy on my left, CEO and Chairman. To his left, we have Jake Orville, who's the General Manager of Screening; and then to his left, we have Megan Jones, who is the VP, Vice President of Investor Relations.

Questions & Answers

Daniel Gregory Brennan
Cowen and Company, LLC, Research Division - Senior Tools & Diagnostics Analyst

So obviously, thank you all for being here. Kevin, last 18 months, a lot has happened. You had the competitive ECLIPSE data come out, exact pull-forward profitability by a year. The Pfizer relationship was terminated and you took on 500 or so sales reps, the pipeline is progressing, new opportunities. So stock has reacted. It's 1 of the best performance recently. It's almost doubled, I think. If you go back to the third

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot